GlassScriptPhysician profile
Marjorie C Ravitz
NPI 1255421442
$1,262.36
in general payments reported to CMS, 2019-2025
18 companies · $60.22 in 2025
The $60.22 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $124 · 2021: $178 · 2022: $180 · 2023: $258 · 2024: $38.34 · 2025: $60.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $214.11 | 2019-2023 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $165.49 | 2019-2023 | Jublia |
| Orthofix Medical, INC. | $141.75 | 2019-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $119.08 | 2021-2024 | Nuzyra |
| Smith+Nephew, INC. | $116.86 | 2023 | Acticoat 4" X 4", Collagenase Santyl, Iodosorb Ointment 40g USA |
| Djo, LLC | $98.13 | 2019-2025 | Cmf |
| Stryker Corporation | $80.59 | 2019-2021 | |
| Sebela Pharmaceuticals INC. | $65.20 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $50.84 | 2019 | |
| Baudax Bio INC. | $40.17 | 2020 | |
| Melinta Therapeutics, LLC | $31.28 | 2019 | |
| Sandoz INC. | $31.28 | 2019 | |
| Abbott Laboratories | $23.00 | 2021 | |
| Amgen INC. | $20.34 | 2024 | Krystexxa |
| Bioventus LLC | $19.64 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $18.68 | 2020 | |
| Heron Therapeutics, INC. | $14.48 | 2022 | |
| Grt US Holding, INC. | $11.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Ravitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.